Summary

The Farm Animal Healthcare Market is poised to grow at a CAGR of 8.2% in the forecast period (2021-2026).

The COVID-19 pandemic is expected to have a significant impact on the market. Extensive information is available regarding coronavirus in animals, with respect to their evolution and pathophysiology. Swine coronavirus disease can be used as a reference for understanding the transmission of coronavirus from one species to another. According to the study of Current Opinion in Virology, in 2019, porcine deltacoronavirus was identified as the causative agent of severe diarrhea outbreaks in North America and Asia, and it emerged from avian deltacoroviruses.

Furthermore, several repeated events have been observed regarding the transmission of the virus in inter-species of animals, and it strongly supports the natural origin of SARS-CoV-2. Many countries had been in lockdown and suspended trades with other countries, leading to a decline in market capitalizations of major companies across the world, along with a decline in industrial production and other businesses. As per Food an Agriculture Organization report, the pandemic situation has heavily impacted on the farm animals and it’s products in terms of supply chain. Therefore, governments are taking measures to mitigate the supply of medicines. For instance, the European Medicines Agency issued guidance for companies responsible for veterinary medicines, with respect to the adaptations to the regulatory framework, primarily to address the challenges faced during this pandemic situation. Hence, a slight short-term negative impact is witnessed on the farm animal healthcare market, during the outbreak of COVID-19.

The major market drivers include advanced technology leading to innovations in animal healthcare, increasing initiatives by the governments and animal welfare associations in different countries and increasing productivity at the risk of emerging zoonosis. According to the World Health Organization (WHO), 2020, currently, there are over 200 prevailing zoonosis diseases across the world, including the new and existing diseases. The UN Food and Agriculture Organization’s report states that most diseases affecting human beings were transferred through animals. With emerging concerns about farm animal health to eradicate zoonotic disease, many protective measurements have been taken, and the best protection from many of these zoonotic diseases is to practice good hygiene after handling animals or their waste. The farm animal healthcare market is largely driven by emerging zoonosis, as it has a large impact on agricultural economies and social life, poses health risks to farm workers, and causes high loss of livelihoods for farmers and farm workers, which necessitates continuous health monitoring of farm animals to prevent their health degradation. Many diseases related to zoonoses have led to a major outbreak in the world. For instance, Black Death, which had its first outbreak in the fourteenth century, continues to exist in several countries, primarily Africa, Madagascar, the Democratic Republic of the Congo, and Peru. Furthermore, recent outbreaks of certain zoonotic diseases, such as Nipah virus, had very few outbreaks in Asia, yet it managed to cause severe diseases in animals, such as pigs. This has increased the demand for diagnostic and therapeutic products in farm animals, as per the World Health Organization. Many of the major zoonotic diseases prevent the efficient production of food of animal origin and create complications to international trade in animal products, which, in turn, encourages appropriate diagnosis and treatment of farm animals and further stimulates the overall farm animal healthcare market to witness strong growth.

Key Market Trends

Parasiticides Represents High Growth Opportunities for Farm Animal Healthcare, Over the Forecast Period

Parasiticides are in high demand, for treating many diseases in farm animals. With the growth of the animal husbandry industry, an excess increase in demand in veterinary pharmaceuticals is expected. Animals are more likely to get infected by internal parasites, which are commonly inclusive of hairworms, lungworms, liver flukes, and coccidia. The external parasites that can be harmful to the animals include, horn flies, lice, and grubs. The parasitic diseases in animals cause disturbed health condition and reproduction, impaired growth, and decreased productivity. Therefore, parasiticides are inevitable for the better animal health. The commonly used parasiticides are levamisole, fenbendazole, oxfendazole, albendazole, moxidectin, eprinomectin, etc. Most of the key players are focusing on innovation in parasiticide products, in order to develop advanced oral dosage forms of parasiticides. For example, in November 2019, Ceva had launched Salmoporc, a salmonella vaccine for pigs, in the United Kingdom and Ireland. Salmoporc gives protection against Salmonella Typhimurium and its monophasic variants. It is administered orally to piglets and through subcutaneous injection in sows.. This has increased the market growth opportunity for the company in in different countries.

North America Dominates the Farm Animal Healthcare Market

North America region is among the major contributor to agriculture, livestock, technological advancements and implementation of farm animal healthcare benefits across the region. The United States is one of the most developed economies across the world. It currently holds the major share of the farm animal healthcare market, and it is expected to follow the same trend over the forecast period. The federal regulation of the United States and the state regulations are responsible for the registration and introduction of the new animal healthcare products in the country. The registration, introduction, or import of such products in the country is strictly done under the surveillance of these regulatory authorities. There are different tests and certifications that are supposed to be cleared. Veterinary vaccines in the United States are regulated by the Center for Veterinary Biologics (CVB) in the Animal and Plant Health Inspection Service (APHIS). The CVB grants establishment and product licenses to animal health companies to manufacture and sell veterinary biologics.

In the United States, advancements in vaccines development include the development of live vector vaccines, nucleic acid-mediated vaccines, live-gene-deleted vaccines, and other vaccines. Boehringer Ingelheim, in 2018, launched a poultry vaccine product, HatchPak IB H120TM NeO, a freeze-dried live attenuated virus of Bronchitis disease, to simplify the vaccination of chicks against the bronchitis virus. In addition to, in June 2020, Huvepharma EOOD, received an US FDA approval for it’s product “Vetmulin12.5%”, an antibiotic used for the treatment of swine dysentery. Hence, these will drive the growth of regional market.

Competitive Landscape

The market is moderately concentrated with a few large players. With large requirements of food supplies and demand for social welfare between human and animals, the companies are highly competitive to invest in the healthcare of farm animals. The market observed major companies merger and acquisition in recent years to enhance their technology and global dominance. Some of the major players include Zoetis, Merck, Boehringer Ingelheim, Elanco, Vetoquinol and Ceva Animal Health.

Reasons to Purchase this report:

- The market estimate (ME) sheet in Excel format
- 3 months of analyst support

ページTOPに戻る

Table of Contents

1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS
4.1 Market Overview
4.2 Introduction to Market Drivers and Restraints
4.3 Market Drivers
4.3.1 Advanced Technology Leading to Innovations in Animal Healthcare
4.3.2 Increasing Initiatives by the Governments and Animal Welfare Associations in Different Countries
4.3.3 Increasing Productivity at the Risk of Emerging Zoonosis
4.4 Market Restraints
4.4.1 Use of Counterfeit Medicines
4.4.2 Increasing Costs of Animal Testing and Veterinary Services
4.5 Porter's Five Force Analysis
4.5.1 Threat of New Entrants
4.5.2 Bargaining Power of Buyers/Consumers
4.5.3 Bargaining Power of Suppliers
4.5.4 Threat of Substitute Products
4.5.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION
5.1 By Product
5.1.1 Vaccines
5.1.2 Parasiticides
5.1.3 Anti-infectives
5.1.4 Medical Feed Additives
5.1.5 Other Products
5.2 By Animal Type
5.2.1 Cattle
5.2.2 Swine
5.2.3 Poultry
5.2.4 Sheep
5.2.5 Other Farm Animals
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 France
5.3.2.2 Germany
5.3.2.3 United Kingdom
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia Pacific
5.3.4 Middle East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Boehringer Ingelheim International GmbH
6.1.2 Ceva Animal Health Inc
6.1.3 Elanco
6.1.4 IDEXX Laboratories
6.1.5 Merck & Co. Inc.
6.1.6 Phibro Animal Health
6.1.7 Vetoquinol
6.1.8 Virbac
6.1.9 Zoetis Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS